Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OR2D3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0007 |
mRNA | MPP1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | RASSF2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
mRNA | C10orf95 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | HMGXB4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | ARHGAP35 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | UBE2V1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
mRNA | TUBB6 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | OR10K1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
mRNA | TUBGCP6 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |